🇺🇸 FDA
Pipeline program

GS-2829

GS-US-642-5670

Phase 1 mab completed

Quick answer

GS-2829 for Chronic Hepatitis B is a Phase 1 program (mab) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences Ireland UC
Indication
Chronic Hepatitis B
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials